Family acute myeloid leukemia / myeloid dysplastic syndrome associated with CEBPA
Vol. 21 No. 2 (2017), Original articles
Vol. 21 No. 2 (2017)

Family acute myeloid leukemia / myeloid dysplastic syndrome associated with CEBPA

Original articles
Published 2019-04-27
Marcelo Iastrebner
R Dourisboure
Centro de Diagnóstico Molecular
L Matilla Méndez
Fundagen
M Tamashiro
Sanatorio Sagrado Corazón
A Chavarri
Sanatorio Sagrado Corazón
M Sorrentino
Sanatorio Sagrado Corazón
A López
Sanatorio Sagrado Corazón
R Rigl
Sanatorio Sagrado Corazón
C Zanardi
Sanatorio Sagrado Corazón
L Rapan
Sanatorio Sagrado Corazón
M Ortiz
Sanatorio Sagrado Corazón
R Campestri
Sanatorio Anchorena, Buenos Aires, Argentina
S Benasayag
Fundagen
ISSN 2250-8309 (versión en línea) - ISSN 0329-0379 (versión impresa)
pdf (Español (España))

Keywords

Family acute myeloid leukemia / myelodysplastic syndrome, CEBPA Family counseling

How to Cite

Iastrebner, M., Dourisboure, R., Matilla Méndez, L., Tamashiro, M., Chavarri, A., Sorrentino, M., López, A., Rigl, R., Zanardi, C., Rapan, L., Ortiz, M., Campestri, R., & Benasayag, S. (2019). Family acute myeloid leukemia / myeloid dysplastic syndrome associated with CEBPA. Journal of Hematology, 21(2), 139–142. Retrieved from https://revistahematologia.com.ar/index.php/Revista/article/view/145
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The diagnosis of family acute myeloid leukemia / myelodysplastic syndrome (AML/MDS) associated with CEBPA requires a special interrogation about family history, specific genetic studies and a family counselling. CEBPA main function is fundamental to the development of myeloid maturation, erythropoiesis and myeloid secondary granule constitution. We describe a case of family AML/MDS where 3 members carry a novel mutation variant in the CEBPA gene.

pdf (Español (España))

References

1. Lin Li et al. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin. Cancer Res. 2005 Feb 15;11(4):1372-9.
2. Vera Grossmann et al. Genomic analysis of germline and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood:120(15) October 11, 2012.
3. Tawana K, Fitzgibbon J. CEBPA-Associated Familial Acute Myeloid Leukemia (AML). 2010 Oct 21 [updated 2016 Apr 28]. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from http://www.ncbi.nlm.nih.gov/books/NBK47457/.
4. Xiao H. et al. First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2011 May 12;117(19):5257-60.
5. Pabst Thomas and Mueller Beatrice U. CEBPA functional domains and mechanisms resulting in CEBPA dysregulation in human AML. Clin. Cancer Res. 2009;15(17).
6. Fasan A. et al. The role of different genetic subtypes of CEBPA mutated AML. Leukemia 2014;28:794-803.
7. Eric M. Nickels, Jesse Soodalter, Jane E. Churpek and Lucy A. Godley. Recognizing familial myeloid leukemia in adults. Ther. Adv. Hematol. 2013,4(4); 254–269.

All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar

Downloads

Download data is not yet available.